New Data from Silence's Atu027 Anticancer Trial Published at ASCO 
Sacramento Bee
Two patients with neuroendocrine cancers had disease stabilisation for nine and 12 months respectively, including partial regression of liver metastases in one patient. Another patient with breast cancer demonstrated regression of liver metastases.
PROACTIVE NEWS SUMMARY: Facebook, Silence Therapeutics, Continental Coal ... Proactive Investors USA & Canada

all 16 news articles » 

Celsion Reports First Quarter 2012 Financial Results 
MarketWatch (press release)
ThermoDox(R) is also being evaluated in two Phase II trials for patients with recurrent chest wall breast cancer and colorectal liver metastases. "With the HEAT Study moving toward final data readout later this year, we have spent this first quarter ...
Celsion Announces Resubmission With Philips Healthcare of Combined IND/IDE ... Benzinga

all 4 news articles » 

Galectin Therapeutics Announces Initiation of Phase 1/2 Trial of Novel ... 
MarketWatch (press release)
... proteins for the therapy of liver fibrosis and cancer, today announced that the first patient has been dosed in a Phase 1/2 trial evaluating the safety and efficacy of a novel treatment combination for the treatment of advanced metastatic melanoma.

and more » 

Pazopanib Works as Sarcoma Salvage Tx 
MedPage Today
By John Gever, Senior Editor, MedPage Today Patients with metastatic soft tissue sarcoma who failed standard chemotherapy had improved progression-free survival when they were treated with pazopanib (Votrient). Point out that the difference in overall ...

and more » 

Galectin Therapeutics Announces Initiation of Phase 1/2 Trial of Novel ... 
EON: Enhanced Online News (press release)
... proteins for the therapy of liver fibrosis and cancer, today announced that the first patient has been dosed in a Phase 1/2 trial evaluating the safety and efficacy of a novel treatment combination for the treatment of advanced metastatic melanoma.

and more » 

Olmsted Falls resident Susan Lewis says The Gathering Place is 'wonderfully ... 
Sun Star Courier
She was diagnosed with metastasis of melanoma, and doctors found spots on her liver, breast and brain. Lewis said sitting in her dermatologist's office, she was in a ?state of denial.? That is when her doctor suggested she consider going to The ...

 

Mount Sinai presents treatment trends, vaccine research, prognosis data at ASCO 
Science Codex
They conducted a retrospective analysis of data from November, 1997, to October, 2010, of 361 patients who were enrolled in Phase II and III clinical trials, and found that functional status; metastases to the lung, liver, or bone; and elevated white ...

and more » 

Genetic Test Identifies Eye Cancer Tumors Likely to Spread 
Science Daily (press release)
"But it's very possible that we can develop treatments to slow the growth of metastatic tumors. The real importance of this test is that by identifying the type of tumor a patient has, we can first remove the tumor from the eye with surgery or ...

and more » 

Sirtex Medical Inc. Announces Third Quarter 2012 Dose Sales 
MarketWatch (press release)
SIR-Spheres microspheres are the only fully FDA-approved microsphere radiation therapy for the treatment of colorectal liver metastases. Globally, Sirtex reported that sales of its SIR-Spheres microspheres targeted radioactive liver cancer treatment ...

and more » 

Pfizer To Present New Data In Advanced Kidney, Lung And Hematologic Cancers At ... 
FiercePharma
At ASCO, Pfizer will present blinded analyses of the association between blood pressure and clinical response from an ongoing Phase 2 study (AGILE 1046) evaluating axitinib in the first-line metastatic RCC (mRCC) treatment setting (Oral presentation, ...

and more »